In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer Patients

Por Vassilakopoulou, Maria, Togun, Taiwo, Dafni, Urania, Cheng, Huan, Bordeaux, Jennifer, Neumeister, Veronique M., Bobos, Mattheos, Pentheroudakis, George, Skarlos, Dimosthenis V., Pectasides, Dimitrios, Kotoula, Vassiliki, Fountzilas, George, Rimm, David L., Psyrri, Amanda
Publicado em 2014

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

Por Fountzilas, George, Christodoulou, Christos, Bobos, Mattheos, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Xanthakis, Ioannis, Batistatou, Anna, Pentheroudakis, George, Xiros, Nikolaos, Papaspirou, Irene, Koumarianou, Anna, Papakostas, Pavlos, Bafaloukos, Dimitrios, Skarlos, Dimosthenis V, Kalogeras, Konstantine T
Publicado em 2012

Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

Por Fountzilas, George, Kotoula, Vassiliki, Pectasides, Dimitrios, Kouvatseas, George, Timotheadou, Eleni, Bobos, Mattheos, Mavropoulou, Xanthipi, Papadimitriou, Christos, Vrettou, Eleni, Raptou, Georgia, Koutras, Angelos, Razis, Evangelia, Bafaloukos, Dimitrios, Samantas, Epaminontas, Pentheroudakis, George, Skarlos, Dimosthenis V.
Publicado em 2013

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies

Por Koletsa, Triantafyllia, Stavridi, Flora, Bobos, Mattheos, Kostopoulos, Ioannis, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Konstantopoulou, Irene, Papadimitriou, Christos, Batistatou, Anna, Gogas, Helen, Koutras, Angelos, Skarlos, Dimosthenis V, Pentheroudakis, George, Efstratiou, Ioannis, Pectasides, Dimitrios, Fountzilas, George
Publicado em 2014

Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study

Por Koukouma Alona, Gikonti Ioanna, Galanidi Eleni, Bai Maria, Bobos Mattheos, Xanthakis Ioannis, Samantas Epaminontas, Kostopoulos Ioannis, Papamichael Dimitrios, Skarlos Dimosthenis V, Vrettou Eleni, Briasoulis Evangelos, Razis Evangelia, Kafiri Georgia, Papakostas Pavlos, Kalogeras Konstantine T, Kosmidis Paris, Fountzilas George
Publicado em 2008-08-01

Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study

Por Razis, Evangelia, Briasoulis, Evangelos, Vrettou, Eleni, Skarlos, Dimosthenis V, Papamichael, Dimitrios, Kostopoulos, Ioannis, Samantas, Epaminontas, Xanthakis, Ioannis, Bobos, Mattheos, Galanidi, Eleni, Bai, Maria, Gikonti, Ioanna, Koukouma, Alona, Kafiri, Georgia, Papakostas, Pavlos, Kalogeras, Konstantine T, Kosmidis, Paris, Fountzilas, George
Publicado em 2008

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

Por Fountzilas, George, Dafni, Urania, Bobos, Mattheos, Batistatou, Anna, Kotoula, Vassiliki, Trihia, Helen, Malamou-Mitsi, Vassiliki, Miliaras, Spyros, Chrisafi, Sofia, Papadopoulos, Savvas, Sotiropoulou, Maria, Filippidis, Theodoros, Gogas, Helen, Koletsa, Triantafyllia, Bafaloukos, Dimitrios, Televantou, Despina, Kalogeras, Konstantine T., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Koutras, Angelos, Dimopoulos, Meletios A.
Publicado em 2012